Fluvoxamine Maleate Capsule, Extended Release
Product Images NDC 69452-182

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fluvoxamine Maleate (NDC 69452-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Structure)

Chemical structure diagram of Fluvoxamine Maleate, depicting its molecular components including aromatic rings, fluorine, and the maleate moiety.*

FDA Label Image

100 mg Capsules (Image01v5)

Fluvoxamine Maleate Extended-Release Capsules 100 mg bottle label showing a 30-capsule count. The label includes dosage strength, NDC 69452-182-13, and instructions to dispense a Medication Guide. It states the capsules are child-resistant and instructs not to crush or chew. Distributed by Bionpharma Inc., made in India.*

FDA Label Image

150 mg Capsules (Image02v5)

Label for Fluvoxamine Maleate Extended-Release Capsules 150 mg, oral dosage form, in a package of 30 capsules. The label indicates it is a prescription drug distributed by Bionpharma Inc. The label includes storage instructions, warnings against crushing or chewing capsules, and requires dispensing the accompanying medication guide. The product is made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.